AHP diet drug settlement
Executive Summary
The $4.75 bil. allocated for the Redux and Pondimin diet drug settlement "remains adequate," American Home Products said April 13 with news that less than 1% of those covered by the nationwide class action litigation opted out of the settlement. "Although a final report has not yet been submitted...approximately 200,000 individuals have registered for the settlement to date and approximately 45,000 opted out during the four month opt-out period that ended on March 30," the company said